Broomfield, J. ., Abrams, K. ., Latimer, N. ., Guglieri, M. ., Rutherford, M. ., & Crowther, M. . (2023). Natural history of Duchenne muscular dystrophy in the United Kingdom: A descriptive study using the Clinical Practice Research Datalink. Brain Behav, 13, e3331. http://doi.org/10.1002/brb3.3331
Adrenal Cortex Hormones
Requena, G. ., Banks, V. ., Czira, A. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2023). Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 18, 231–245. http://doi.org/10.2147/copd.s389281
Chen, S. ., Miravitlles, M. ., Rhee, C. K., Pavord, I. D., Jones, R. ., Carter, V. ., … Price, D. B. (2022). Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy. Int J Chron Obstruct Pulmon Dis, 17, 2187–2200. http://doi.org/10.2147/copd.s378649
Czira, A. ., Banks, V. ., Requena, G. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2022). Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England. BMJ Open Respir Res, 9. http://doi.org/10.1136/bmjresp-2022-001243
Suissa, S. ., Dell’Aniello, S. ., & Ernst, P. . (2022). Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety. Int J Chron Obstruct Pulmon Dis, 17, 1975–1986. http://doi.org/10.2147/copd.s378486
Requena, G. ., Banks, V. ., Czira, A. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2022). Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β(2)-Agonist Dual Therapy in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 17, 1781–1795. http://doi.org/10.2147/copd.s365480
Rothnie, K. J., Joksaite, S. ., Sansbury, L. B., Compton, C. ., Di Boscio, V. ., & Ismaila, A. S. (2022). Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 17, 1455–1466. http://doi.org/10.2147/copd.s338436
Suissa, S. ., Dell’Aniello, S. ., & Ernst, P. . (2022). Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice. Copd, 19, 133–141. http://doi.org/10.1080/15412555.2022.2045265